This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2025. Click here to view PDF

PathCare is pleased to announce that, from 12 January 2026, we will provide plasma metanephrine (MN), normetanephrine (NMN), and 3-methoxytyramine (3MT) measured using High-Resolution Accurate-Mass

PathCare will now offer simultaneous measurement of salivary cortisol and cortisone using liquid chromatography-high-resolution mass spectrometry (LC-HRMS). Click here to view PDF

PathCare has developed a unique reporting tool which consolidates pathology results for diabetic patients.   This report allows healthcare providers to assess diabetes management performance of

This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during September 2025 (epidemiological weeks 36-39). Click

Laboratory-based data for all GIT molecular panels requested for patients at PathCare laboratories nationally, for the period June to August 2025, are presented in this